UHC Medicare Certification Independent Practice
Questions & Answers | Comprehensive Medicare
Training & Exam Preparation Study Guide |
UnitedHealthcare Medicare Concepts, Medicare
Advantage (MA), Medicare Part D, Eligibility &
Enrollment, Plan Benefits, Member Rights,
Compliance, Agent Training, Privacy,
Communication Standards, Regulatory Concepts &
Detailed Rationales
Question 1: A Medicare Advantage (MA) plan is considering implementing a
new utilization management policy that requires prior authorization for all
outpatient MRI services. Under Medicare rules, which of the following is the
MOST critical requirement that must be included in the policy to ensure
compliance?
A. The policy must be approved by the state Department of Insurance before
implementation.
B. The policy must be based on clinical criteria that are reviewed and updated at least
quarterly.
C. The policy must be applied consistently to both Medicare and non-Medicare
members.
D. The policy must be submitted to the Centers for Medicare & Medicaid Services
(CMS) for a 30-day public comment period.
CORRECT ANSWER: B. The policy must be based on clinical criteria that are
reviewed and updated at least quarterly.
Rationale: Medicare guidelines require that utilization management policies, including
prior authorization, be based on sound clinical criteria that are reviewed and updated at
least annually, but quarterly is a best practice and aligns with the expectation for current
medical evidence. State DOI approval is not a federal Medicare requirement. The policy
applies to Medicare members, and while consistency is good practice, it is not the
critical compliance element. CMS does not require a public comment period for internal
plan policies.
Question 2: An Ultra High-Cost (UHC) Medicare beneficiary is enrolled in a
Medicare Advantage Prescription Drug (MAPD) plan. The beneficiary has a
complex medical history and is taking several specialty drugs. The plan's
pharmacy benefit manager (PBM) has placed one of the drugs on a higher tier
for the upcoming year. What is the plan's PRIMARY obligation to the
beneficiary regarding this change?
A. Send a letter informing the beneficiary of the change 30 days prior to the effective
date.
B. Provide a 60-day transition fill at the previous cost-sharing if the change is effective
mid-year.
,C. Allow the beneficiary to appeal the tier change directly to CMS.
D. Waive the cost-sharing difference for the first 90 days of the new plan year.
CORRECT ANSWER: B. Provide a 60-day transition fill at the previous cost-
sharing if the change is effective mid-year.
Rationale: For mid-year formulary changes that increase cost-sharing or restrict
access, plans must provide a 60-day transition supply at the previous cost-sharing. A 30-
day notice is required for Annual Notice of Changes (ANOC), not for mid-year changes.
Appeals are made through the plan's internal process, not directly to CMS. Waiving cost-
sharing for 90 days is not a standard Medicare requirement.
Question 3: A UHC Medicare broker is assisting a beneficiary with a Special
Enrollment Period (SEP) due to a permanent move out of the plan's service
area. The beneficiary wants to enroll in a new Medicare Advantage plan. What
is the correct timeframe for the SEP and the effective date of enrollment?
A. The SEP begins the month before the move and ends two months after; coverage is
effective the first of the month after enrollment.
B. The SEP begins the month before the move and ends two months after; coverage is
effective the first of the month after the move.
C. The SEP begins the month of the move and ends two months after; coverage is
effective the first of the month after enrollment.
D. The SEP begins the month after the move and ends three months after; coverage is
effective the first of the month after the move.
CORRECT ANSWER: C. The SEP begins the month of the move and ends two
months after; coverage is effective the first of the month after enrollment.
Rationale: The SEP for a permanent move out of the service area begins the month of
the move and continues for two full calendar months after. The effective date of
coverage is the first of the month following the month the plan receives the enrollment
request.
Question 4: Under Medicare Part D, which of the following statements
accurately describes the "Coverage Gap" (Donut Hole) for 2026 for brand-name
drugs, assuming standard parameters?
A. The beneficiary pays 25% of the cost for brand-name drugs, and the manufacturer
discount does not apply.
B. The beneficiary pays 25% of the cost for brand-name drugs, and the manufacturer
discount covers 10% of the cost.
C. The beneficiary pays 25% of the cost for brand-name drugs, and the plan covers 75%
of the cost.
D. The beneficiary pays 25% of the cost for brand-name drugs, and the manufacturer
discount covers 70% of the cost.
CORRECT ANSWER: A. The beneficiary pays 25% of the cost for brand-name
drugs, and the manufacturer discount does not apply.
,Rationale: Under the Inflation Reduction Act, the Coverage Gap was effectively
eliminated for 2025 and beyond. Beneficiaries pay 25% of the cost for both brand-name
and generic drugs in what was the gap. The manufacturer discount no longer applies as
the gap no longer exists in the same way; the plan covers a larger portion earlier.
Question 5: A UHC Medicare plan is conducting its annual health risk
assessment (HRA) for a new enrollee. During the assessment, the nurse
identifies that the beneficiary is at high risk for falls. Which of the following
actions is the plan MOST required to take based on this finding?
A. Schedule a home safety evaluation within 30 days.
B. Provide a list of local physical therapists to the beneficiary.
C. Document the risk in the beneficiary's care management record and provide targeted
education.
D. Enroll the beneficiary in a disease management program for osteoporosis.
CORRECT ANSWER: C. Document the risk in the beneficiary's care
management record and provide targeted education.
Rationale: While a home safety evaluation or physical therapy referral may be
appropriate, the immediate and required action is to document the risk and provide
education. The HRA is a tool for identification and intervention planning, and
documentation is foundational for any subsequent steps. Enrollment in a specific
program like osteoporosis is only indicated if that condition is also identified.
Question 6: In the context of UHC Medicare's Stars quality rating program,
which of the following measures is classified as a "Part C" (Medicare
Advantage) clinical outcome measure?
A. Annual flu shot.
B. Controlling high blood pressure.
C. Medication adherence for diabetes medications.
D. Customer service responsiveness.
CORRECT ANSWER: B. Controlling high blood pressure.
Rationale: Controlling high blood pressure is a clinical outcome measure under Part C
that assesses the percentage of members with hypertension whose blood pressure is
adequately controlled. Annual flu shot is a preventive measure. Medication adherence is
a Part D measure. Customer service is a patient experience/complaint measure.
Question 7: A UHC Medicare plan is terminating its contract with a
participating provider who has a history of quality of care issues. What is the
plan's obligation to its enrolled beneficiaries who are currently seeing this
provider?
A. The plan must immediately disenroll all beneficiaries seeing that provider.
B. The plan must provide a 30-day notice to affected beneficiaries and offer assistance in
finding a new provider.
, C. The plan must continue to cover services from that provider for a 90-day transition
period.
D. The plan must notify CMS and request a waiver for continuity of care.
CORRECT ANSWER: C. The plan must continue to cover services from that
provider for a 90-day transition period.
Rationale: When a provider contract is terminated, especially for quality reasons, the
plan must offer a 90-day continuity of care period for existing beneficiaries to transition
their care to a new provider. This is a CMS requirement to protect beneficiary access to
care.
Question 8: What is the PRIMARY purpose of the Medicare Annual Election
Period (AEP), which runs from October 15 to December 7?
A. To allow beneficiaries to enroll in a Medicare Advantage plan for the first time.
B. To allow beneficiaries to change from one Medicare Advantage plan to another or
switch between MA and Original Medicare.
C. To allow beneficiaries to enroll in a Medicare Supplement (Medigap) plan without
medical underwriting.
D. To allow beneficiaries to review their plan's Annual Notice of Change (ANOC) and
provide feedback.
CORRECT ANSWER: B. To allow beneficiaries to change from one Medicare
Advantage plan to another or switch between MA and Original Medicare.
Rationale: The AEP is the primary period when beneficiaries can change their
Medicare health and prescription drug coverage for the upcoming year, including
switching MA plans or moving to Original Medicare. Initial enrollment is for first-time
enrollees. Medigap has separate enrollment rules. ANOC review is a part of the process
but is not the primary purpose of the period itself.
Question 9: A beneficiary is enrolled in a UHC Medicare Advantage HMO plan
and needs to see a specialist for a chronic condition. What is the MOST critical
step the beneficiary must take to ensure coverage for the specialist visit?
A. Confirm that the specialist is in the plan's network.
B. Obtain a referral from the Primary Care Physician (PCP).
C. Verify that the specialist accepts Medicare assignment.
D. Pre-authorize the visit with the plan's utilization management department.
CORRECT ANSWER: B. Obtain a referral from the Primary Care Physician
(PCP).
Rationale: In an HMO plan, the hallmark feature is the requirement for a referral from
the PCP for specialist services. While being in-network is also required, the referral is the
critical, defining step for coverage in an HMO. Medicare assignment is for Original
Medicare. Pre-authorization is for specific procedures, not typically for an initial
consultation.
Questions & Answers | Comprehensive Medicare
Training & Exam Preparation Study Guide |
UnitedHealthcare Medicare Concepts, Medicare
Advantage (MA), Medicare Part D, Eligibility &
Enrollment, Plan Benefits, Member Rights,
Compliance, Agent Training, Privacy,
Communication Standards, Regulatory Concepts &
Detailed Rationales
Question 1: A Medicare Advantage (MA) plan is considering implementing a
new utilization management policy that requires prior authorization for all
outpatient MRI services. Under Medicare rules, which of the following is the
MOST critical requirement that must be included in the policy to ensure
compliance?
A. The policy must be approved by the state Department of Insurance before
implementation.
B. The policy must be based on clinical criteria that are reviewed and updated at least
quarterly.
C. The policy must be applied consistently to both Medicare and non-Medicare
members.
D. The policy must be submitted to the Centers for Medicare & Medicaid Services
(CMS) for a 30-day public comment period.
CORRECT ANSWER: B. The policy must be based on clinical criteria that are
reviewed and updated at least quarterly.
Rationale: Medicare guidelines require that utilization management policies, including
prior authorization, be based on sound clinical criteria that are reviewed and updated at
least annually, but quarterly is a best practice and aligns with the expectation for current
medical evidence. State DOI approval is not a federal Medicare requirement. The policy
applies to Medicare members, and while consistency is good practice, it is not the
critical compliance element. CMS does not require a public comment period for internal
plan policies.
Question 2: An Ultra High-Cost (UHC) Medicare beneficiary is enrolled in a
Medicare Advantage Prescription Drug (MAPD) plan. The beneficiary has a
complex medical history and is taking several specialty drugs. The plan's
pharmacy benefit manager (PBM) has placed one of the drugs on a higher tier
for the upcoming year. What is the plan's PRIMARY obligation to the
beneficiary regarding this change?
A. Send a letter informing the beneficiary of the change 30 days prior to the effective
date.
B. Provide a 60-day transition fill at the previous cost-sharing if the change is effective
mid-year.
,C. Allow the beneficiary to appeal the tier change directly to CMS.
D. Waive the cost-sharing difference for the first 90 days of the new plan year.
CORRECT ANSWER: B. Provide a 60-day transition fill at the previous cost-
sharing if the change is effective mid-year.
Rationale: For mid-year formulary changes that increase cost-sharing or restrict
access, plans must provide a 60-day transition supply at the previous cost-sharing. A 30-
day notice is required for Annual Notice of Changes (ANOC), not for mid-year changes.
Appeals are made through the plan's internal process, not directly to CMS. Waiving cost-
sharing for 90 days is not a standard Medicare requirement.
Question 3: A UHC Medicare broker is assisting a beneficiary with a Special
Enrollment Period (SEP) due to a permanent move out of the plan's service
area. The beneficiary wants to enroll in a new Medicare Advantage plan. What
is the correct timeframe for the SEP and the effective date of enrollment?
A. The SEP begins the month before the move and ends two months after; coverage is
effective the first of the month after enrollment.
B. The SEP begins the month before the move and ends two months after; coverage is
effective the first of the month after the move.
C. The SEP begins the month of the move and ends two months after; coverage is
effective the first of the month after enrollment.
D. The SEP begins the month after the move and ends three months after; coverage is
effective the first of the month after the move.
CORRECT ANSWER: C. The SEP begins the month of the move and ends two
months after; coverage is effective the first of the month after enrollment.
Rationale: The SEP for a permanent move out of the service area begins the month of
the move and continues for two full calendar months after. The effective date of
coverage is the first of the month following the month the plan receives the enrollment
request.
Question 4: Under Medicare Part D, which of the following statements
accurately describes the "Coverage Gap" (Donut Hole) for 2026 for brand-name
drugs, assuming standard parameters?
A. The beneficiary pays 25% of the cost for brand-name drugs, and the manufacturer
discount does not apply.
B. The beneficiary pays 25% of the cost for brand-name drugs, and the manufacturer
discount covers 10% of the cost.
C. The beneficiary pays 25% of the cost for brand-name drugs, and the plan covers 75%
of the cost.
D. The beneficiary pays 25% of the cost for brand-name drugs, and the manufacturer
discount covers 70% of the cost.
CORRECT ANSWER: A. The beneficiary pays 25% of the cost for brand-name
drugs, and the manufacturer discount does not apply.
,Rationale: Under the Inflation Reduction Act, the Coverage Gap was effectively
eliminated for 2025 and beyond. Beneficiaries pay 25% of the cost for both brand-name
and generic drugs in what was the gap. The manufacturer discount no longer applies as
the gap no longer exists in the same way; the plan covers a larger portion earlier.
Question 5: A UHC Medicare plan is conducting its annual health risk
assessment (HRA) for a new enrollee. During the assessment, the nurse
identifies that the beneficiary is at high risk for falls. Which of the following
actions is the plan MOST required to take based on this finding?
A. Schedule a home safety evaluation within 30 days.
B. Provide a list of local physical therapists to the beneficiary.
C. Document the risk in the beneficiary's care management record and provide targeted
education.
D. Enroll the beneficiary in a disease management program for osteoporosis.
CORRECT ANSWER: C. Document the risk in the beneficiary's care
management record and provide targeted education.
Rationale: While a home safety evaluation or physical therapy referral may be
appropriate, the immediate and required action is to document the risk and provide
education. The HRA is a tool for identification and intervention planning, and
documentation is foundational for any subsequent steps. Enrollment in a specific
program like osteoporosis is only indicated if that condition is also identified.
Question 6: In the context of UHC Medicare's Stars quality rating program,
which of the following measures is classified as a "Part C" (Medicare
Advantage) clinical outcome measure?
A. Annual flu shot.
B. Controlling high blood pressure.
C. Medication adherence for diabetes medications.
D. Customer service responsiveness.
CORRECT ANSWER: B. Controlling high blood pressure.
Rationale: Controlling high blood pressure is a clinical outcome measure under Part C
that assesses the percentage of members with hypertension whose blood pressure is
adequately controlled. Annual flu shot is a preventive measure. Medication adherence is
a Part D measure. Customer service is a patient experience/complaint measure.
Question 7: A UHC Medicare plan is terminating its contract with a
participating provider who has a history of quality of care issues. What is the
plan's obligation to its enrolled beneficiaries who are currently seeing this
provider?
A. The plan must immediately disenroll all beneficiaries seeing that provider.
B. The plan must provide a 30-day notice to affected beneficiaries and offer assistance in
finding a new provider.
, C. The plan must continue to cover services from that provider for a 90-day transition
period.
D. The plan must notify CMS and request a waiver for continuity of care.
CORRECT ANSWER: C. The plan must continue to cover services from that
provider for a 90-day transition period.
Rationale: When a provider contract is terminated, especially for quality reasons, the
plan must offer a 90-day continuity of care period for existing beneficiaries to transition
their care to a new provider. This is a CMS requirement to protect beneficiary access to
care.
Question 8: What is the PRIMARY purpose of the Medicare Annual Election
Period (AEP), which runs from October 15 to December 7?
A. To allow beneficiaries to enroll in a Medicare Advantage plan for the first time.
B. To allow beneficiaries to change from one Medicare Advantage plan to another or
switch between MA and Original Medicare.
C. To allow beneficiaries to enroll in a Medicare Supplement (Medigap) plan without
medical underwriting.
D. To allow beneficiaries to review their plan's Annual Notice of Change (ANOC) and
provide feedback.
CORRECT ANSWER: B. To allow beneficiaries to change from one Medicare
Advantage plan to another or switch between MA and Original Medicare.
Rationale: The AEP is the primary period when beneficiaries can change their
Medicare health and prescription drug coverage for the upcoming year, including
switching MA plans or moving to Original Medicare. Initial enrollment is for first-time
enrollees. Medigap has separate enrollment rules. ANOC review is a part of the process
but is not the primary purpose of the period itself.
Question 9: A beneficiary is enrolled in a UHC Medicare Advantage HMO plan
and needs to see a specialist for a chronic condition. What is the MOST critical
step the beneficiary must take to ensure coverage for the specialist visit?
A. Confirm that the specialist is in the plan's network.
B. Obtain a referral from the Primary Care Physician (PCP).
C. Verify that the specialist accepts Medicare assignment.
D. Pre-authorize the visit with the plan's utilization management department.
CORRECT ANSWER: B. Obtain a referral from the Primary Care Physician
(PCP).
Rationale: In an HMO plan, the hallmark feature is the requirement for a referral from
the PCP for specialist services. While being in-network is also required, the referral is the
critical, defining step for coverage in an HMO. Medicare assignment is for Original
Medicare. Pre-authorization is for specific procedures, not typically for an initial
consultation.
